A Strategic Partnership in Immuno-Oncology The landscape of cancer treatment is evolving rapidly, and a recent announcement highlights a significant step forward. GeorgiaMune, a biotechnology company focused on innovative medical solutions, has entered into an exclusive global licensing and collaboration agreement with the Menarini Group. This partnership centers on the development of GIM-621, a promising…